Chemotherapy to Survive; Fitness to Thrive
Mike Levine switched oncologists to find chemotherapy that works on his pancreatic cancer. After that he was able to compete in the Ironman Triathlon.
Mike Levine switched oncologists to find chemotherapy that works on his pancreatic cancer. After that he was able to compete in the Ironman Triathlon.
A clinical trial examines the effectiveness of presurgical chemotherapy and radiation in making cancer-free margins after tumor removal.
Can neoadjuvant treatment such as chemoradiation make pancreatic cancer removal surgery more effective? That is the question asked by this clinical trial.
Leslie Wineberg started her pancreatic cancer treatment with chemotherapy and radiation but was glad to qualify for irreversible electroporation (IRE).
After her diagnosis of pancreatic cancer, Shannon Magee became patient 1 in a new clinical trial that combined chemotherapy and a Whipple procedure.
Working with his oncologist, Dr. Mark Fishman decided to follow non-standard alternating protocols to treat his pancreatic cancer.
Bill Shrieves was ready to start a clinical trial for pancreatic cancer when it was found to have spread. He was successfully treated with FOLFIRINOX.
A clinical trial compares standard chemotherapy with and without the addition of a PARP inihibitor, for patients whose pancreatic cancer is spreading again.
Samuel Chi describes his search for a pancreatic cancer treatment that allows him to live comfortably and reduce his tumor so he can have surgery.
A clinical trial compares FOLFIRINOX plus stereotactic body radiation therapy (SBRT) with just FOLFIRINOX for pancreatic cancer that has spread locally.